BriaCell Therapeutics (BCTX) Competitors $3.55 -0.01 (-0.28%) Closing price 04:00 PM EasternExtended Trading$3.65 +0.10 (+2.93%) As of 07:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BCTX vs. BDRX, ADVM, IRD, XLO, NBRV, RNXT, PMVP, KPTI, ANEB, and CNTBShould you be buying BriaCell Therapeutics stock or one of its competitors? The main competitors of BriaCell Therapeutics include Biodexa Pharmaceuticals (BDRX), Adverum Biotechnologies (ADVM), Opus Genetics (IRD), Xilio Therapeutics (XLO), Nabriva Therapeutics (NBRV), RenovoRx (RNXT), PMV Pharmaceuticals (PMVP), Karyopharm Therapeutics (KPTI), Anebulo Pharmaceuticals (ANEB), and Connect Biopharma (CNTB). These companies are all part of the "pharmaceutical products" industry. BriaCell Therapeutics vs. Biodexa Pharmaceuticals Adverum Biotechnologies Opus Genetics Xilio Therapeutics Nabriva Therapeutics RenovoRx PMV Pharmaceuticals Karyopharm Therapeutics Anebulo Pharmaceuticals Connect Biopharma Biodexa Pharmaceuticals (NASDAQ:BDRX) and BriaCell Therapeutics (NASDAQ:BCTX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, media sentiment, community ranking, profitability, earnings, dividends and risk. Does the MarketBeat Community prefer BDRX or BCTX? BriaCell Therapeutics received 12 more outperform votes than Biodexa Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformBiodexa PharmaceuticalsOutperform Votes1100.00% Underperform VotesNo VotesBriaCell TherapeuticsOutperform Votes13100.00% Underperform VotesNo Votes Is BDRX or BCTX more profitable? Company Net Margins Return on Equity Return on Assets Biodexa PharmaceuticalsN/A N/A N/A BriaCell Therapeutics N/A N/A -191.19% Does the media prefer BDRX or BCTX? In the previous week, BriaCell Therapeutics had 1 more articles in the media than Biodexa Pharmaceuticals. MarketBeat recorded 2 mentions for BriaCell Therapeutics and 1 mentions for Biodexa Pharmaceuticals. Biodexa Pharmaceuticals' average media sentiment score of 0.80 beat BriaCell Therapeutics' score of 0.00 indicating that Biodexa Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biodexa Pharmaceuticals 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BriaCell Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk and volatility, BDRX or BCTX? Biodexa Pharmaceuticals has a beta of 1.15, indicating that its stock price is 15% more volatile than the S&P 500. Comparatively, BriaCell Therapeutics has a beta of 1.38, indicating that its stock price is 38% more volatile than the S&P 500. Which has preferable earnings & valuation, BDRX or BCTX? BriaCell Therapeutics has lower revenue, but higher earnings than Biodexa Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiodexa Pharmaceuticals$83K574.14-$7.66MN/AN/ABriaCell TherapeuticsN/AN/A-$4.79M-$5.03-0.71 Do insiders and institutionals believe in BDRX or BCTX? 17.5% of Biodexa Pharmaceuticals shares are held by institutional investors. Comparatively, 15.4% of BriaCell Therapeutics shares are held by institutional investors. 0.3% of Biodexa Pharmaceuticals shares are held by company insiders. Comparatively, 5.7% of BriaCell Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Do analysts prefer BDRX or BCTX? BriaCell Therapeutics has a consensus target price of $32.00, suggesting a potential upside of 795.10%. Given BriaCell Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe BriaCell Therapeutics is more favorable than Biodexa Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biodexa Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00BriaCell Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryBriaCell Therapeutics beats Biodexa Pharmaceuticals on 8 of the 12 factors compared between the two stocks. Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BCTX vs. The Competition Export to ExcelMetricBriaCell TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.28M$6.55B$5.40B$8.53BDividend YieldN/A2.66%5.22%4.11%P/E Ratio-0.279.1626.7419.97Price / SalesN/A258.53394.93122.22Price / CashN/A65.8538.2534.62Price / Book-1.636.546.874.59Net Income-$4.79M$143.98M$3.23B$248.18M7 Day Performance19.17%4.65%5.01%2.15%1 Month Performance-14.68%9.18%12.82%16.14%1 Year Performance-84.42%-1.33%17.63%8.06% BriaCell Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BCTXBriaCell Therapeutics1.3089 of 5 stars$3.55-0.3%$32.00+801.4%-84.1%$13.17MN/A-0.278News CoverageBDRXBiodexa Pharmaceuticals0.8732 of 5 stars$1.29+0.8%N/AN/A$47.14M$83,000.000.0020News CoverageADVMAdverum Biotechnologies3.7754 of 5 stars$2.21+4.2%$26.40+1,094.6%-69.7%$46.17M$1M-0.37190Analyst RevisionIRDOpus Genetics2.0531 of 5 stars$1.01-1.0%$7.33+626.1%N/A$45.94M$10.99M-0.9314Earnings ReportXLOXilio Therapeutics2.6506 of 5 stars$0.88+2.4%$4.00+354.5%-28.1%$45.57M$9.27M-0.5170NBRVNabriva TherapeuticsN/AN/AN/AN/A$45.46M$35.59M0.0070RNXTRenovoRx2.6686 of 5 stars$1.24+5.1%$7.00+464.5%-12.9%$45.32M$43,000.00-2.186Positive NewsEarnings ReportAnalyst ForecastAnalyst RevisionHigh Trading VolumePMVPPMV Pharmaceuticals1.7146 of 5 stars$0.87+0.9%$5.50+529.3%-57.9%$44.99MN/A-0.8750KPTIKaryopharm Therapeutics3.8643 of 5 stars$5.13-3.6%$43.20+742.1%-69.8%$44.32M$142.13M-5.03380Gap DownANEBAnebulo Pharmaceuticals2.2588 of 5 stars$1.06+3.9%$5.50+418.9%-53.0%$43.55MN/A-3.794CNTBConnect Biopharma3.2985 of 5 stars$0.78+4.5%$8.00+919.2%-49.2%$43.44M$26.03M0.00110News CoverageEarnings Report Related Companies and Tools Related Companies BDRX Alternatives ADVM Alternatives IRD Alternatives XLO Alternatives NBRV Alternatives RNXT Alternatives PMVP Alternatives KPTI Alternatives ANEB Alternatives CNTB Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BCTX) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BriaCell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BCTX Stock Free BCTX Stock Alerts